API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.co.uk/news-releases/first-and-only-recombinant-von-willebrand-factor-treatment-for-adults-with-von-willebrand-disease-the-most-common-inherited-bleeding-disorder-1-recommended-for-routine-commissioning-via-nhs-england-814703238.html
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004454/WC500255625.pdf
http://www.pharmatimes.com/news/shires_veyvondi_approved_in_europe_for_bleeding_disorder_1251914